Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
EpiSante Biomedical specializes in DNA methylation-based cancer detection, offering early screening, post-surgery monitoring, and personalized treatment solutions. The company developed Asia's first liver cancer DNA methylation detection kit and the world's first methylation-based prognostic and ablation monitoring products for liver cancer.
Parse Score